Dr. Navaneeth Reddy Hasthavaram Specialist Medical Oncology
Years of Experience : 11
Nationality : India
Languages Known : English, Hindi, Telugu
Education & Training: DrNB (Medical Oncology), DNB (Radiation Oncology), MBBS
Book AppointmentBiography
Dr. Navaneeth Reddy Hasthavaram is a board-certified Specialist Medical Oncologist with extensive experience in managing a wide spectrum of solid tumors and hematologic malignancies. His areas of expertise include breast, lung, gastrointestinal, hepatobiliary, urinary tract, and gynecological cancers, as well as sarcomas and lymphomas. He is proficient in delivering advanced cancer treatments such as chemotherapy, immunotherapy, targeted therapy, and intrathecal chemotherapy. In addition to systemic therapies, he is skilled in performing key oncological procedures including bone marrow aspiration and biopsy, PICC line insertion and CSF sampling. He also has a strong focus on preventive oncology through genetic counselling, cancer screening, and immunization programs. Dr. Navaneeth has played a significant role in establishing and streamlining oncology departments, ensuring efficient clinical workflows and high standards of patient care. He is experienced in training multidisciplinary teams and contributing to clinical research, with involvement in study design, data interpretation, and academic publications. He is adept at managing complex treatment protocols involving chemotherapy, immunotherapy, and targeted therapies, while effectively addressing treatment-related complications and providing palliative care to improve patient quality of life. In addition to his medical oncology expertise, he has a background in radiation oncology, with procedural knowledge in interstitial brachytherapy for gynecological malignancies, head and neck cancers, breast cancer, and sarcomas. Known for his clinical acumen, ethical approach, and patient-centered care, Dr. Navaneeth is committed to delivering comprehensive, multidisciplinary cancer treatment
Research & Publications
- High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option
- Radiation-induced volume changes in salivary glands using IMRT
- RT dose correlation with dysphagia in head and neck cancers
- Diagnosing Primary Malignancy in Leptomeningeal Carcinomatosis by CSF Cytology
- Persistent antibody response to SARS-CoV-2 in cancer patients
- Qualitative and dosimetric xerostomia study: 3DCRT vs. IMRT
Expertise
- Cancer Screening & Vaccination Programs
- Diagnosis and management
- Chemotherapy, Immunotherapy
- Bone Marrow Biopsy & Aspiration
- Hormonal & Gene Directed therapy
- Intrathecal chemotherapy and Targeted therapy
- PICC Line Insertion
- Genetic Counselling & Patient Education
- BMT and CAR-T cell therapy
- Therapy associated adverse effects management
- Oncology Department Setup & Daycare Training
- Organising CME
- Clinical Study Design, Data Interpretation & Publications
- Palliative Care & Extravasation Management
Certification
- DOH License for Specialist Medical Oncology – 21st Nov 2025
- DHA License for Specialist Medical Oncology – March 2025
Membership
- ISMPO – Indian Society of Medical & Pediatric Oncology (Lifetime)
- ICON Trust – Indian Cooperative Oncology Network (Lifetime)
- ESMO – certification in medical Oncology to education details (Lifetime)
- ASCO – American Society of Clinical Oncology
- SITC – Society for Immunotherapy of Cancer
Blogs
